Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics. - Wikidata - awgldk - TriplyDB

Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics.

Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics.

http://www.wikidata.org/entity/Q33540001

about

Structural basis for bifunctional peptide recognition at human δ-opioid receptor Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.Molecular Pharmacology of δ-Opioid Receptors.

P2860

Q27644624-F1F2EAD4-883F-4153-8CAE-91B8B3839228 Q33747010-8FB8C656-F5FC-4292-B9C9-42608E9E52B6 Q33910425-1E80E9A8-D091-4844-B78F-7F5F5985DCC3 Q37062556-58E5C481-C75C-4858-BE9B-9FE4BE0569C6

P2860

Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics.

http://www.wikidata.org/entity/Q33540001

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@ast

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@en

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@nl

type

label

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@ast

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@en

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@nl

prefLabel

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@ast

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@en

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@nl

P1433

Q33540001-74596BF5-28DE-4F35-B3E1-A8E2BAB2E5DC

P1476

Q33540001-783DED43-EB1A-41E5-89E0-191DBBB84C54

P2093

Q33540001-17F9F3C3-0311-4EA4-9DF2-D879F075D646

Q33540001-2A381FEB-AB1E-41AC-9CAB-DC0BD7B9EB6F

Q33540001-77077007-2824-4AF6-A4B0-AC86F5205937

Q33540001-86959F74-D6F1-4FB2-A67E-7E87E059DECA

Q33540001-9A0F0622-6EE6-42E1-A771-6A40FA02570C

Q33540001-AFBA1BCC-4825-43FF-A1EE-6491AF69EA76

Q33540001-DE5475C3-5C8D-4213-9E54-7EC4E6D74FF4

Q33540001-EA2B952F-B2D2-47BC-9856-039237DE24DE

Q33540001-F1164A2D-412A-4F4B-A0BB-B02D0F2E0D11

P2860

Q33540001-0789D8DB-ADD0-45B8-BD5F-DBB97A8B540E

Q33540001-3A71BA9D-B40F-4898-A500-208DCDE26DCC

Q33540001-3BEBF0CC-3ED3-4943-93BD-3C4A9DFA50B8

Q33540001-44074499-C2F4-483A-A745-3772F43D4555

Q33540001-50E5B84E-3325-4623-9E70-3077AE7B3A30

Q33540001-6020B20C-7FD3-4D5D-B4A1-31C2F8C1D34C

Q33540001-898165CA-ACB0-4639-89D0-70EAEC40BAD2

Q33540001-948FE337-CD9F-4EF9-B7C8-291FBC2A078C

Q33540001-967B9F91-9DDB-4942-BF3C-353B730E8537

Q33540001-A0CBC7ED-CD2A-4DD8-8210-AB3D45B71898

P304

Q33540001-C07BF0A8-4F49-4DDC-9B21-87268C8FC22B

P31

Q33540001-2E1BA827-1C9B-4B58-A063-4B3E959CA2BF

P356

Q33540001-C9D242A3-32F9-4385-BB4B-ACBE22F4774B

P433

Q33540001-BB7182A4-A21C-44DD-9551-86A435A29805

P478

Q33540001-13A347C9-F3DA-4567-B031-0E4690B7B08D

P577

Q33540001-8BD687AA-3630-4C05-BB98-772E0D0BA79B

P698

Q33540001-98DF5043-F82B-4DDC-BB8C-896E514F1E6A

P921

Q33540001-ff120d08-c3a6-4f24-8c81-8df09467479e

P356

10799899909036673

P1433

Journal of Receptors and Signal Transduction

P1476

Subtleties of structure-agonis ...... peptides and peptidomimetics.

@en

P2093

Berezowska I

http://www.w3.org/2001/XMLSchema#string

Carpenter KA

http://www.w3.org/2001/XMLSchema#string

Chung NN

http://www.w3.org/2001/XMLSchema#string

Lemieux C

http://www.w3.org/2001/XMLSchema#string

Nguyen TM

http://www.w3.org/2001/XMLSchema#string

Schiller PW

http://www.w3.org/2001/XMLSchema#string

Schmidt R

http://www.w3.org/2001/XMLSchema#string

Weltrowska G

http://www.w3.org/2001/XMLSchema#string

Wilkes BC

http://www.w3.org/2001/XMLSchema#string

P2860

Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity

N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11)

Opiate antagonistic properties of an octapeptide somatostatin analog

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.

Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor

Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.

Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.

Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.

Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist.

P304

573-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10799899909036673

http://www.w3.org/2001/XMLSchema#string

P433

1-4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10071786

http://www.w3.org/2001/XMLSchema#string

P921